European Commission: We haven't renewed the contract with AstraZeneca, we'll see more

European Commissioner for the Only Thierry Breton Market said today that the European Commission has not yet ordered a vaccine from the British-Swedish company AstraZeneca after June, when existing contracts are expired, Reuters reports. The European Commission established a judicial process against AstraZeneca last month for disregarding contract provisions for the supply of coronary vaccines. Company [...]
The European Commission established a judicial process against AstraZeneca last month for disregarding contract provisions for the supply of coronary vaccines.
The British-Swedish pharmaceutical company is also criticised for the lack of a reliable “plan that would enable the distribution of doses on time.
We did not renew the order after June. We'll see what happens next. AstraZeneca is a very good vaccine, “tha Breton for French radio EInter.
He added that he expects the latest order for new doses of Pfizer vaccines/ B ONTech be more expensive than in previous versions.
The EU recently signed a new agreement with American-German vaccine producers, which should receive 1.8 billion doses by 2023.
The “may cost a little bit more, but I will let competent people talk about it in a predictable future,” said Bretton.












